Skip to main content

Carruthers Wendy's Form 4 filing

Boston Scientific Corp (BSX) · filed Aug 15, 2023

Accession no.
0001225208-23-008245
Filed
Aug 15, 2023
Trade date
Aug 15, 2023
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $598.7K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Carruthers WendyCIK 0001563565Officer (EVP, Human Resources)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 15, 2023Common StockMOption exerciseAcquired+3,448$16.31+$56,236.8871,032Direct
Aug 15, 2023Common StockMOption exerciseAcquired+2,960$13.08+$38,716.873,992Direct
Aug 15, 2023Common StockSSaleDisposed−11,671$51.30F2−$598,722.362,321Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 15, 2023Common StockMOption exerciseDisposed−3,448$0.00$013,794Direct
Aug 15, 2023Common StockMOption exerciseDisposed−2,960$0.00$011,839Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.19 to $51.41, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)